लोड हो रहा है...
Brivaracetam: a novel antiepileptic drug for focal-onset seizures
Brivaracetam (BRV), the n-propyl analogue of levetiracetam (LEV), is the latest antiepileptic drug (AED) to be licensed in Europe and the USA for the adjunctive treatment of focal-onset seizures with or without secondary generalization in patients aged 16 years or older. Like LEV, BRV binds to synap...
में बचाया:
| में प्रकाशित: | Ther Adv Neurol Disord |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
SAGE Publications
2017
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5784556/ https://ncbi.nlm.nih.gov/pubmed/29399049 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285617742081 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|